T. Rowe Price Associates
SYNH

T. Rowe Price Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

T. Rowe Price Associates’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-33,400
Closed -$1.41M – 2926
2023
Q2 		$1.41M Buy
+33,400
New +$1.35M ﹤0.01% 1624

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

T. Rowe Price Associates's SYNH Position: Q3 2023 in Review

T. Rowe Price Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 39,783 shares — an estimated $1.68M sold.

T. Rowe Price Associates first reported a position in SYNH in Q4 2015 and held it in 31 quarters. The position peaked at $31M in Q2 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • T. Rowe Price Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 39,783 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.68M.
  • T. Rowe Price Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 31 quarters.
  • T. Rowe Price Associates's Syneos Health, Inc. Class A Common Stock position peaked at $31M in Q2 2017.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.